{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T08:09:21Z","timestamp":1782461361383,"version":"3.54.5"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.anndiagpath.2024.152372","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T03:59:05Z","timestamp":1724385545000},"page":"152372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["From the archives of MD Anderson Cancer Center: Composite mantle cell lymphoma and lymphoplasmacytic lymphoma involving bone marrow at presentation"],"prefix":"10.1016","volume":"73","author":[{"given":"Yiannis Petros","family":"Dimopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beenu","family":"Thakral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokce","family":"Toruner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Leventaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.anndiagpath.2024.152372_bb0005","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/ajh.26523","article-title":"Mantle cell lymphoma in 2022-a comprehensive update on molecular pathogenesis, risk stratification, clinical approach, and current and novel treatments","volume":"97","author":"Jain","year":"2022","journal-title":"Am J Hematol"},{"issue":"7","key":"10.1016\/j.anndiagpath.2024.152372_bb0010","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.anndiagpath.2024.152372_bb0015","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.anndiagpath.2024.152372_bb0020","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1182\/blood-2018-07-862151","article-title":"CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1(-) mantle cell lymphoma","volume":"133","author":"Martin-Garcia","year":"2019","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.anndiagpath.2024.152372_bb0025","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/cncr.11096","article-title":"Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma","volume":"97","author":"Romaguera","year":"2003","journal-title":"Cancer"},{"issue":"20","key":"10.1016\/j.anndiagpath.2024.152372_bb0030","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1158\/0008-5472.CAN-12-1615","article-title":"Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features","volume":"72","author":"Navarro","year":"2012","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.anndiagpath.2024.152372_bb0035","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ajh.26796","article-title":"Waldenstrom macroglobulinemia: 2023 update on diagnosis, risk stratification, and management","volume":"98","author":"Gertz","year":"2023","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2024.152372_bb0040","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/ajh.23880","article-title":"Extramedullary Waldenstrom macroglobulinemia","volume":"90","author":"Banwait","year":"2015","journal-title":"Am J Hematol"},{"issue":"10","key":"10.1016\/j.anndiagpath.2024.152372_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105570","article-title":"MYD88 mutations: transforming the landscape of IgM monoclonal gammopathies","volume":"23","author":"Alcoceba","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.anndiagpath.2024.152372_bb0050","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/ajcp\/aqy041","article-title":"Defining lymphoplasmacytic lymphoma: does MYD88L265P define a pathologically distinct entity among patients with an IgM paraprotein and bone marrow-based low-grade B-cell lymphomas with plasmacytic differentiation?","volume":"150","author":"Fang","year":"2018","journal-title":"Am J Clin Pathol"},{"issue":"10","key":"10.1016\/j.anndiagpath.2024.152372_bb0055","doi-asserted-by":"crossref","first-page":"e435","DOI":"10.1016\/S1470-2045(14)70153-6","article-title":"Pathogenesis, diagnosis, and treatment of composite lymphomas","volume":"15","author":"Kuppers","year":"2014","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2024.152372_bb0060","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2559.2001.01120.x","article-title":"Pathology of lymphoma progression","volume":"38","author":"Muller-Hermelink","year":"2001","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.anndiagpath.2024.152372_bb0065","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.humpath.2011.08.024","article-title":"Mantle cell lymphoma as a component of composite lymphoma: clinicopathologic parameters and biologic implications","volume":"43","author":"Papathomas","year":"2012","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2024.152372_bb0070","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1309\/9DBY-FBUG-Y10A-AAXT","article-title":"Lymphoplasmacytic lymphoma\/Waldenstrom macroglobulinemia associated with Hodgkin disease. A report of two cases","volume":"116","author":"Rosales","year":"2001","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"10.1016\/j.anndiagpath.2024.152372_bb0075","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/00000478-200308000-00007","article-title":"Waldenstrom macroglobulinemia involving extramedullary sites: morphologic and immunophenotypic findings in 44 patients","volume":"27","author":"Lin","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2024.152372_bb0080","first-page":"10","article-title":"Concomitant lymphoplasmacytic lymphoma and plasma cell myeloma, a diagnostic challenge","volume":"7","author":"Mansour","year":"2017","journal-title":"Am J Blood Res"},{"issue":"7","key":"10.1016\/j.anndiagpath.2024.152372_bb0085","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/pin.12937","article-title":"Composite monoclonal B-cell lymphocytosis and MYD88 L265P-positive lymphoplasmacytic lymphoma in a patient with IgM light chain amyloidosis: case report","volume":"70","author":"Oishi","year":"2020","journal-title":"Pathol Int"},{"issue":"1","key":"10.1016\/j.anndiagpath.2024.152372_bb0090","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/ajcp\/96.1.81","article-title":"A clinicopathologic analysis of nine patients with Hodgkin\u2019s disease and B-cell non-Hodgkin\u2019s lymphoma","volume":"96","author":"Gonzalez","year":"1991","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2024.152372_bb0095","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/ajcp\/99.4.445","article-title":"Composite lymphoma and related disorders","volume":"99","author":"Kim","year":"1993","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2024.152372_bb0100","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1309\/AJCPHXO5UGW2OELA","article-title":"Composite chronic lymphocytic leukemia\/small lymphocytic lymphoma and follicular lymphoma are biclonal lymphomas: a report of two cases","volume":"137","author":"Boiocchi","year":"2012","journal-title":"Am J Clin Pathol"},{"issue":"16","key":"10.1016\/j.anndiagpath.2024.152372_bb0105","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1182\/blood.2019000858","article-title":"Impact of concurrent indolent lymphoma on the clinical outcome of newly diagnosed diffuse large B-cell lymphoma","volume":"134","author":"Wang","year":"2019","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.anndiagpath.2024.152372_bb0110","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0002-9440(10)65443-0","article-title":"Composite low grade B-cell lymphomas with two immunophenotypically distinct cell populations are true biclonal lymphomas. A molecular analysis using laser capture microdissection","volume":"154","author":"Fend","year":"1999","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2024.152372_bb0115","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1309\/AJCPAWDDYO5OQYCD","article-title":"A unique composite follicular lymphoma and mantle cell lymphoma with a mixed cell pattern and aggressive course","volume":"141","author":"Liu","year":"2014","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2024.152372_bb0120","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s12185-020-03035-0","article-title":"Pathological and molecular analysis of a composite lymphoma of mantle cell lymphoma and Epstein-Barr virus-positive follicular lymphoma","volume":"113","author":"Miyazawa","year":"2021","journal-title":"Int J Hematol"},{"issue":"9","key":"10.1016\/j.anndiagpath.2024.152372_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.153067","article-title":"Composite follicular lymphoma and \u201cearly\u201d (in situ and mantle zone growth pattern) mantle cell neoplasia: a rare entity with peculiar cytogenetic and clinical features","volume":"216","author":"Vivian","year":"2020","journal-title":"Pathol Res Pract"},{"issue":"2","key":"10.1016\/j.anndiagpath.2024.152372_bb0130","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1309\/AJCP06VIKFMTRCXD","article-title":"Multifocal mantle cell lymphoma in situ in the setting of a composite lymphoma","volume":"143","author":"Sloan","year":"2015","journal-title":"Am J Clin Pathol"},{"issue":"22","key":"10.1016\/j.anndiagpath.2024.152372_bb0135","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1182\/blood.2019000012","article-title":"Follicular lymphoma with composite in situ mantle cell neoplasia","volume":"133","author":"Subtil","year":"2019","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.anndiagpath.2024.152372_bb0140","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3324\/haematol.2011.052621","article-title":"In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior","volume":"97","author":"Carvajal-Cuenca","year":"2012","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.anndiagpath.2024.152372_bb0145","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.humpath.2012.04.022","article-title":"Composite mantle cell lymphoma and chronic lymphocytic leukemia\/small lymphocytic lymphoma: a clinicopathologic and molecular study","volume":"44","author":"Hoeller","year":"2013","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2024.152372_bb0150","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1182\/blood.2020009288","article-title":"Composite mantle cell lymphoma and small lymphocytic lymphoma in a lymph node","volume":"137","author":"Mass","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.anndiagpath.2024.152372_bb0155","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/cyto.b.21512","article-title":"Composite mantle cell lymphoma and chronic lymphocytic leukemia\/small lymphocytic lymphoma","volume":"94","author":"Sun","year":"2018","journal-title":"Cytometry B Clin Cytom"},{"issue":"4","key":"10.1016\/j.anndiagpath.2024.152372_bb0160","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.humpath.2006.08.023","article-title":"Composite splenic marginal zone lymphoma and mantle cell lymphoma arising from 2 independent B-cell clones","volume":"38","author":"Lefebvre","year":"2007","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2024.152372_bb0165","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cancergencyto.2006.06.018","article-title":"Mantle cell lymphoma arising within primary nodal marginal zone lymphoma: a unique presentation of two uncommon B-cell lymphoproliferative disorders","volume":"171","author":"Rodig","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"issue":"7","key":"10.1016\/j.anndiagpath.2024.152372_bb0170","article-title":"The diagnostic and treatment challenges of concomitant mantle cell lymphoma and IgM myeloma","volume":"9","author":"Gor","year":"2022","journal-title":"Eur J Case Rep Intern Med"},{"issue":"8","key":"10.1016\/j.anndiagpath.2024.152372_bb0175","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1097\/00000478-200608000-00004","article-title":"Mantle cell lymphoma with plasma cell differentiation","volume":"30","author":"Young","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.anndiagpath.2024.152372_bb0180","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/modpathol.2015.99","article-title":"Plasma cell and terminal B-cell differentiation in mantle cell lymphoma mainly occur in the SOX11-negative subtype","volume":"28","author":"Ribera-Cortada","year":"2015","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2024.152372_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.5769","article-title":"Concomitant lymphoplasmacytic lymphoma, multiple myeloma, and amyloidosis: a diagnostic and therapeutic challenge","volume":"10","author":"Ceballos","year":"2022","journal-title":"Clin Case Rep"},{"issue":"5","key":"10.1016\/j.anndiagpath.2024.152372_bb0190","first-page":"649","article-title":"Annual meeting abstracts, November 7\u201310, 2007 Los Angeles, California","volume":"9","author":"Association for Molecular Pathology 2007","year":"2007","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.anndiagpath.2024.152372_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.602868","article-title":"B-cell-specific Myd88 L252P expression causes a premalignant gammopathy resembling IgM MGUS","volume":"11","author":"Schmidt","year":"2020","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2024.152372_bb0200","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.hemonc.2020.10.003","article-title":"Frequency of MYD88 L256P mutation and its correlation with clinico-hematological profile in mature B-cell neoplasm","volume":"14","author":"Shekhar","year":"2021","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"19","key":"10.1016\/j.anndiagpath.2024.152372_bb0205","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1182\/blood-2008-10-185827","article-title":"Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): importance for interactions with the stromal microenvironment and specific targeting","volume":"113","author":"Kurtova","year":"2009","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.anndiagpath.2024.152372_bb0210","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41375-020-01102-3","article-title":"CXCR4 in Waldenstrom\u2019s Macroglobulinema: chances and challenges","volume":"35","author":"Kaiser","year":"2021","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.anndiagpath.2024.152372_bb0215","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/bjh.13361","article-title":"MYD88 L265P and CXCR4 mutations in lymphoplasmacytic lymphoma identify cases with high disease activity","volume":"169","author":"Schmidt","year":"2015","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.anndiagpath.2024.152372_bb0220","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41408-020-00351-w","article-title":"Clinicopathological characterization of chronic lymphocytic leukemia with MYD88 mutations: L265P and non-L265P mutations are associated with different features","volume":"10","author":"Shuai","year":"2020","journal-title":"Blood Cancer J"},{"issue":"6","key":"10.1016\/j.anndiagpath.2024.152372_bb0225","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/jclinpath-2015-202862","article-title":"LEF1: a highly specific marker for the diagnosis of chronic lymphocytic B cell leukaemia\/small lymphocytic B cell lymphoma","volume":"68","author":"Menter","year":"2015","journal-title":"J Clin Pathol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2024.152372_bb0230","first-page":"292","article-title":"Diagnostic utility of lymphoid enhancer binding factor 1 immunohistochemistry in small B-cell lymphomas","volume":"147","author":"Menter","year":"2017","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2024.152372_bb0235","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/ajcp\/aqz207","article-title":"Immunohistochemical expression of lymphoid enhancer binding factor 1 in CD5-positive marginal zone, Lymphoplasmacytic, and follicular lymphomas","volume":"153","author":"Patel","year":"2020","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"10.1016\/j.anndiagpath.2024.152372_bb0240","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1080\/17474086.2023.2270779","article-title":"New developments in the diagnosis and characterization of Waldenstrom\u2019s macroglobulinemia","volume":"16","author":"Garcia-Sanz","year":"2023","journal-title":"Expert Rev Hematol"},{"issue":"8","key":"10.1016\/j.anndiagpath.2024.152372_bb0245","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2017.72","article-title":"From Waldenstrom\u2019s macroglobulinemia to aggressive diffuse large B-cell lymphoma: a whole-exome analysis of abnormalities leading to transformation","volume":"7","author":"Jimenez","year":"2017","journal-title":"Blood Cancer J"},{"issue":"5","key":"10.1016\/j.anndiagpath.2024.152372_bb0250","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3324\/haematol.2017.184325","article-title":"A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trial","volume":"103","author":"Bomben","year":"2018","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.anndiagpath.2024.152372_bb0255","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/bjh.15567","article-title":"Long-term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib","volume":"183","author":"Jain","year":"2018","journal-title":"Br J Haematol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913424001096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913424001096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T06:29:39Z","timestamp":1731652179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913424001096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":51,"alternative-id":["S1092913424001096"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2024.152372","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From the archives of MD Anderson Cancer Center: Composite mantle cell lymphoma and lymphoplasmacytic lymphoma involving bone marrow at presentation","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2024.152372","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152372"}}